Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick B Ryan

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
EGEMS (Washington, DC)|April 8, 2015
Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data ModelRupa Makadia, Patrick B Ryan
Diabetes, Obesity & Metabolism|August 24, 2018
Comment on "Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D)"Patrick B Ryan, Norm Rosenthal
Drug Safety|October 30, 2013
Evaluating performance of risk identification methods through a large-scale simulation of observational dataPatrick B Ryan, Martijn J Schuemie
Therapeutic Advances in Drug Safety|August 2, 2014
Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studiesDavid Madigan, Patrick B Ryan, Martijn Schuemie
Drug Safety|October 30, 2013
Empirical performance of the case-control method: lessons for developing a risk identification and analysis systemDavid Madigan, Martijn J Schuemie, Patrick B Ryan
Drug Safety|October 30, 2013
Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis systemPatrick B Ryan, Martijn J Schuemie, David Madigan
Drug Safety|October 30, 2013
Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis systemMartijn J Schuemie, David Madigan, Patrick B Ryan
Journal of Biomedical Informatics|August 2, 2019
PheValuator: Development and evaluation of a phenotype algorithm evaluatorJoel N Swerdel, George Hripcsak, Patrick B Ryan
BMC Medical Research Methodology|April 19, 2015
The impact of standardizing the definition of visits on the consistency of multi-database observational health researchErica A Voss, Qianli Ma, Patrick B Ryan
Drug Safety|July 9, 2015
A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug ReactionsYing Li, Patrick B Ryan, Ying Wei, et al.
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
EGEMS (Washington, DC)|April 8, 2015
Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data ModelRupa Makadia, Patrick B Ryan
Diabetes, Obesity & Metabolism|August 24, 2018
Comment on "Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D)"Patrick B Ryan, Norm Rosenthal
Drug Safety|October 30, 2013
Evaluating performance of risk identification methods through a large-scale simulation of observational dataPatrick B Ryan, Martijn J Schuemie
Therapeutic Advances in Drug Safety|August 2, 2014
Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studiesDavid Madigan, Patrick B Ryan, Martijn Schuemie
Drug Safety|October 30, 2013
Empirical performance of the case-control method: lessons for developing a risk identification and analysis systemDavid Madigan, Martijn J Schuemie, Patrick B Ryan
Drug Safety|October 30, 2013
Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis systemPatrick B Ryan, Martijn J Schuemie, David Madigan
Drug Safety|October 30, 2013
Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis systemMartijn J Schuemie, David Madigan, Patrick B Ryan
Journal of Biomedical Informatics|August 2, 2019
PheValuator: Development and evaluation of a phenotype algorithm evaluatorJoel N Swerdel, George Hripcsak, Patrick B Ryan
BMC Medical Research Methodology|April 19, 2015
The impact of standardizing the definition of visits on the consistency of multi-database observational health researchErica A Voss, Qianli Ma, Patrick B Ryan
Drug Safety|July 9, 2015
A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug ReactionsYing Li, Patrick B Ryan, Ying Wei, et al.
Pageof 17